Pepticom's New Spinout Company, PeptiCov, to Focus on COVID-19 - 10 March 2021 11:01

JERUSALEM, March 10, 2021 /PRNewswire-AsiaNet/ -- Pepticom, a leader in artificial intelligence peptide drug design and discovery, announced today that it has raised $2.6 million to establish a company to focus on treatments for the SARS-Cov-2 virus, responsible for the COVID-19 outbreak. The...

  Cytiva and Longitude (a Financial Times company) reveal five m... - 09 March 2021 18:00

AMERSHAM, United Kingdom, March 9, 2021 /PRNewswire-AsiaNet/ -- - A survey of 1,165 biopharma executives and healthcare policymakers across 20 countries measured ability of industry to respond to global needs in five areas: Supply chain resilience, talent pool, R&D ecosystem, manufacturing agility, and governm...

  Patients Win When Support Is Personalized: New Study From Atla... - 08 March 2021 08:00

SYDNEY, March 8, 2021 /PRNewswire-AsiaNet/ -- Leading patient outcomes journal Patient Preference and Adherence [ https://doi.org/10.2147/PPA.S293941 ] has published a study that demonstrates significant improvement in treatment behaviors among patients with neovascular age-related macular de...

  MedAlliance Receives Fourth FDA Breakthrough Device Designatio... - 04 March 2021 10:00

NYON, Switzerland, March 4, 2021 /PRNewswire-AsiaNet/ -- MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR(TM), its ...

  Cipla receives final approval for generic version of GlaxoSmit... - 02 March 2021 18:56

MUMBAI, India, 02 March 2021 /PRNewswire-AsiaNet/ -- Cipla Limited (BSE: 500087); (NSE: CIPLA EQ) (hereinafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray, 20 mg from the United States Foo...

  Cipla Gulf Expands Partnership with Alvotech for Commercializa... - 02 March 2021 18:40

MUMBAI, India, March. 2, 2021/PRNewswire-AsiaNet/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its subsidiary, Cipla Gulf FZ LCC ("Cipla Gulf')is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines ...

  INOVIO Announces Positive Results from REVEAL 1, a Phase 3 Piv... - 02 March 2021 08:39

PLYMOUTH MEETING, Pa., March 2, 2021 /PRNewswire-AsiaNet/ -- -- Trial achieved primary and secondary efficacy endpoints among all evaluable subjects in the Phase 3 multi-center, randomized, double-blind, placebo-controlled trial -- VGX-3100 is the first DNA medicine to achieve efficacy endpoints in a Pha...

  Lennar Named #1 Homebuilder Worldwide on FORTUNE Magazine's 20... - 01 March 2021 21:00

MIAMI, March 1, 2021 /PRNewswire-AsiaNet/ -- Lennar Corporation (NYSE: LEN and LEN.B), the nation's leading homebuilder, today announced that it has been named #1 Most Admired Homebuilder on FORTUNE Magazine's 2021 List of World's Most Admired Companies ( https://c212.net/c/link/?t=0&l=en&o=...

  TVM Capital Healthcare Exits Cambridge Medical and Rehabilitat... - 01 March 2021 18:35

SINGAPORE, March 1, 2021 /PRNewswire-AsiaNet/ -- TVM Capital Healthcare, a global specialist healthcare private equity firm operating in emerging markets, announces the successful sale of its portfolio company Cambridge Medical and Rehabilitation Center ("CMRC") to UAE-based publicly traded ...

  Debiopharm And Genome & Company Join Forces To Create New High... - 26 February 2021 23:11

LAUSANNE, Switzerland and SEONGNAM-SI GYEONGGI-DO, South Korea, Feb. 26, 2021 /PRNewswire/ - Korean and Swiss based companies leverage their oncology expertise to initiate a research collaboration to formulate novel antibody-drug conjugate (ADC) candidates Genome & Company (CEO: Jisoo Pae, Hansoo Park), a global leading immuno-oncolo...